Edition:
United States

Jounce Therapeutics Inc (JNCE.OQ)

JNCE.OQ on NASDAQ Stock Exchange Global Select Market

3.53USD
14 Dec 2018
Change (% chg)

$-0.16 (-4.34%)
Prev Close
$3.69
Open
$3.60
Day's High
$3.77
Day's Low
$3.50
Volume
55,379
Avg. Vol
77,120
52-wk High
$29.02
52-wk Low
$3.31

Chart for

About

Jounce Therapeutics, Inc. is a clinical stage immunotherapy company. The Company is engaged in transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long lasting benefits to patients. Through the use of its Translational Science Platform, Jounce first focuses on... (more)

Overall

Beta: --
Market Cap(Mil.): $137.02
Shares Outstanding(Mil.): 32.70
Dividend: --
Yield (%): --

Financials

  JNCE.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -1.07 -- --
ROI: -16.58 0.60 13.80
ROE: -24.92 -2.18 15.29

Earnings vs. Estimates